Koninklijke Philips (PHG) Gains from Investment Securities (2009 - 2026)
Koninklijke Philips' (PHG) quarterly Gains from Investment Securities came in at $15.2 million in Q1 2026, up 823.45% year-on-year from $1.6 million in Q1 2025, and down 49.71% quarter-over-quarter from $30.3 million in Q4 2025.
Koninklijke Philips (PHG) Gains from Investment Securities (2009 - 2026) Analysis & Trends
Koninklijke Philips' Gains from Investment Securities history runs 17 years deep, the most recent figure standing at $15.2 million for Q1 2026.
- On a quarterly basis, Gains from Investment Securities rose 823.45% year-over-year to $15.2 million in Q1 2026; TTM through Mar 2026 was $44.3 million, a 300.18% increase from a year earlier, with the FY2025 full-year figure at $26.8 million, up 231.87% from the prior year.
- Gains from Investment Securities slipped to $15.2 million in Q1 2026 per PHG's latest filing, from $30.3 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $30.3 million in Q4 2025 and bottomed at -$117.3 million in Q4 2022.
- The 5-year median for Gains from Investment Securities is -$2.1 million (2025), against an average of -$15.0 million.
- Across the five-year window, Gains from Investment Securities sank 121.29% in 2025 and jumped 823.45% in 2026, its largest moves.
- Year by year, Gains from Investment Securities stood at -$117.3 million in 2022, then soared by 34.89% to -$76.4 million in 2023, then soared by 60.83% to -$29.9 million in 2024, then surged by 201.15% to $30.3 million in 2025, then sank by 49.71% to $15.2 million in 2026.
- Per Business Quant, the three latest PHG Gains from Investment Securities figures stand at $15.2 million (Q1 2026), $30.3 million (Q4 2025), and -$2.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.22 Mn |
| Mar 31, 2026 | 15.22 Mn |
| Dec 31, 2025 | 30.27 Mn |
| Dec 31, 2025 | 30.27 Mn |
| Sep 30, 2025 | -2.34 Mn |
| Sep 30, 2025 | -2.34 Mn |
| Jun 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | -2.10 Mn |
| Mar 31, 2025 | -2.10 Mn |
| Dec 31, 2024 | -29.92 Mn |
| Dec 31, 2024 | -29.92 Mn |
| Sep 30, 2024 | 10.98 Mn |
| Sep 30, 2024 | 10.98 Mn |
| Jun 30, 2024 | -1.08 Mn |
| Jun 30, 2024 | -1.08 Mn |
| Mar 31, 2024 | -1.09 Mn |
| Mar 31, 2024 | -1.09 Mn |
| Dec 31, 2023 | -76.39 Mn |
| Dec 31, 2023 | -76.39 Mn |